Pityriasis rubra pilaris partially responsive to treatment with upadacitinib: A case report
Authors:
Open Access
- 1 January 2023
- journal article
- research article
- Published by SAGE Publications in Sage Open Medical Case Reports
- Vol. 11
Abstract
Pityriasis rubra pilaris is a rare inflammatory dermatosis characterized by orange-red confluent plaques, hyperkeratotic follicular papules, palmoplantar keratoderma, and, in some cases, erythroderma. The etiology of pityriasis rubra pilaris is unclear. This condition is often treated with oral retinoids and topical corticosteroids, and more recently, biological agents have become the mainstay of treatment. However, there is a paucity of high-quality evidence on the safety and effectiveness of these agents, and the disease often remains refractory to therapy. Herein, we present a case of pityriasis rubra pilaris with a favorable response to treatment with upadacitinib, a Janus kinase inhibitor, which has not been previously reported in the literature for the management of this condition.Keywords
This publication has 16 references indexed in Scilit:
- Secukinumab for the treatment of adult-onset pityriasis rubra pilaris: a single-arm clinical trial with transcriptomic analysisBritish Journal of Dermatology, 2022
- Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic DermatitisJAMA Dermatology, 2021
- Evaluation of Ixekizumab Treatment for Patients With Pityriasis Rubra PilarisJAMA Dermatology, 2020
- Biologics for pityriasis rubra pilaris treatment: A review of the literatureJournal of the American Academy of Dermatology, 2018
- A Review on Pityriasis Rubra PilarisAmerican Journal of Clinical Dermatology, 2018
- Janus kinase inhibitors in dermatology: A systematic reviewJournal of the American Academy of Dermatology, 2017
- Interleukin 23–Helper T Cell 17 Axis as a Treatment Target for Pityriasis Rubra PilarisJAMA Dermatology, 2017
- Topical tofacitinib for atopic dermatitis: a phaseIIa randomized trialBritish Journal of Dermatology, 2016
- Treatment Options for Pityriasis Rubra Pilaris Including Biologic AgentsJAMA Dermatology, 2014
- Pityriasis rubra pilaris response to 13-cis-retinoic acid (isotretinoin)Journal of the American Academy of Dermatology, 1982